. 2018 Jun 5;16(2):847–855. doi: 10.3892/etm.2018.6250

Table II.

The count of Bcl-2 positive cells, Bcl-2 mRNA, Bcl-2 protein of rats hippocampus area in each group (mean ± standard deviation, n=10).

Groups	Bcl-2 positive cells	Bcl-2 mRNA	Bcl-2
Control group	23.197±2.726	0.440±0.076	0.349±0.049
Model group	29.606±2.143^a	0.605±0.051^a	0.508±0.044^a
rHuEpo treated group	42.639±1.829^a–c	0.984±0.019^a–c	0.791±0.045^a–c
LY294002 treated group	35.415±2.011^a,b	0.843±0.034^a,b	0.636±0.021^a,b
LY294002 control group	41.060±0.476^a–c	0.981±0.021^a–c	0.762±0.050^a–c
F-value	19.27	27.95	18.07
P-value	<0.05	<0.05	<0.05

P<0.05, control group vs. model group, rHuEpo treated, LY294002 treated, LY294002 control groups

P<0.05, model group vs. rHuEpo treated, LY294002 treated, LY294002 control groups

P<0.05, LY294002 treated group vs. rHuEpo treated, LY294002 control groups. No significant difference was found between rHuEpo treated group and LY294002 control group. rHuEpo, recombinant human erythropoietin.